Sequence variation analysis of the E2 gene of human papilloma virus type 16 in cervical lesions from women in Greece

Archives of Virology

Volumn 157, Issue 5, 2012, Pages 825-832

  Tsakogiannis, D ^a   Ruether, I G A ^a   Kyriakopoulou, Z ^a   Pliaka, V ^a   Theoharopoulou, A ^a   Skordas, V ^a   Panotopoulou, E ^b   Nepka, C ^c   Markoulatos, P ^a  

^a UNIVERSITY OF THESSALY   (Greece)

^b Papanicolaou Research Centre of Oncology and Experimental Surgery   (Greece)

^c UNIVERSITY HOSPITAL OF LARISSA   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

DNA BINDING PROTEIN; E2 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 16; ONCOPROTEIN;

ARTICLE; CHEMISTRY; CLASSIFICATION; FEMALE; GENETIC VARIABILITY; GENETICS; GREECE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; ISOLATION AND PURIFICATION; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PAPILLOMAVIRUS INFECTION; PHYLOGENY; PROTEIN TERTIARY STRUCTURE; UTERINE CERVIX CARCINOMA IN SITU; VIROLOGY;

BASE SEQUENCE; CERVICAL INTRAEPITHELIAL NEOPLASIA; DNA-BINDING PROTEINS; FEMALE; GENETIC VARIATION; GREECE; HUMAN PAPILLOMAVIRUS 16; HUMANS; MOLECULAR SEQUENCE DATA; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRUS INFECTIONS; PHYLOGENY; PROTEIN STRUCTURE, TERTIARY;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16;

EID: 84860476373     PISSN: 03048608     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00705-012-1236-8     Document Type: Article

References (51)

1. Bernard HU, Burk RD, Chen Z, van Doorslaer K, Hausen H, de Villiers EM (2010) Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments. Virology 401: 70-79.
2. Zur Hausen H (1996) Papillomavirus infections-a major cause of human cancers. Biochim Biophys Acta 1288: F55-F78.
3. Bernard HU, Calleja-Macias IE, Dunn ST (2006) Genome variation of human papillomavirus types: phylogenetic and medical implications. Int J Cancer 118: 1071-1076.
4. Yamada T, Wheeler CM, Halpern AL, Stewart ACM, Hildesheim A, Jenison SA (1995) Human Papillomavirus type 16 variant lineages in United States populations characterized by nucleotide sequence analysis of the E6, L2 and L1 coding segments. J Virol 69: 7743-7753.
5. Bosch FX, Burchell AN, Schiffman M, Giuliano AR, de Sanjose S, Bruni L, Tortolero-Luna G, Kjaer SK, Muñoz N (2008) Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia. Vaccine 26: K1-K17.
6. Schiffman M, Clifford G, Buonaguro FM (2009) Classification of weakly carcinogenic human papillomavirus types: addressing the limits of epidemiology at the borderline. Infect Agent Cancer 4: 8.
7. Sundström K, Eloranta S, Sparén P, Arnheim Dahlström L et al (2010) Prospective study of human papillomavirus (HPV) types, HPV persistence, and risk of squamous cell carcinoma of the cervix. Cancer Epidemiol Biomarkers Prev 19: 2469-2478.
8. Castle PE, Schiffman M, Wheeler CM, Wentzensen N, Gravitt PE (2010) Human papillomavirus genotypes in cervical intraepithelial neoplasia grade 3. Cancer Epidemiol Biomarkers Prev 19: 1675-1681.
9. Bruni L, Diaz M, Castellsagué X, Ferrer E, Bosch FX, de Sanjosé S (2010) Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. J Infect Dis 202: 1789-1799.
10. Dong SM, Kim HS, Rha SH, Sidransky D (2001) Promoter hypermethylation of multiple genes in carcinoma of the uterine cervix. Clin Cancer Res 7: 1982-1986.
11. Feng Q, Balasubramanian A, Hawes SE, Toure P, Sow PS, Dem A, Dembele B, Critchlow CW, Xi L, Lu H, McIntosh MW, Young AM, Kiviat NB (2005) Detection of hypermethylated genes in women with and without cervical neoplasia. J Natl Cancer Inst 97: 273-282.
12. Smotkin D, Wettstein FO (1986) Transcription of human papillomavirus type 16 early genes in a cervical cancer and a cancer-derived cell line and identification of the E7 protein. Proc Natl Acad Sci USA 83: 4680-4684.
13. Soeda E, Ferran MC, Baker CC, McBride AA (2006) Repression of HPV16 early region transcription by the E2 protein. Virology 351: 29-41.
14. Longworth MS, Laimins LA (2004) Pathogenesis of human papillomaviruses in differentiating epithelia. Microbiol Mol Biol Rev 68: 362-372.
15. Hamid NA, Brown C, Gaston K (2009) The regulation of cell proliferation by the papillomavirus early proteins. Cell Mol Life Sci 66: 1700-1717.
16. Huang LW, Choa SL, Lee BH, Lee BH (2008) Integration of human papillomavirus type-16 and type-18 is a very early event in cervical carcinogenesis. J Clin Pathol 61: 627-631.
17. Cricca M, Morselli-Labate AM, Venturoli S et al (2007) Viral DNA load, physical status and E2/E6 ratio as markers to grade HPV16 positive women for high-grade cervical lesions. Gynecol Oncol 106(549): 557.
18. Briolat J, Dalstein V, Saunier M et al (2007) HPV prevalence, viral load and physical state of HPV-16 in cervical smears of patients with different grades of CIN. Int J Cancer 121: 2198-2204.
19. Arias-Pulido H, Peyton CL, Joste NE, Vargas H, Wheeler CM (2006) Human papillomavirus type 16 integration in cervical carcinoma in situ and in invasive cervical cancer. J Clin Microbiol 44: 1755-1762.
20. Li W, Wang W, Si M et al (2008) The physical state of HPV16 infection and its clinical significance in cancer precursor lesion and cervical carcinoma. J Cancer Res Clin Oncol 134: 1355-1361.
21. Tonon SA, Picconi MA, Bos PD, Zinovich JB, Galuppo J, Alonio LV, Teyssie AR (2001) Physical status of the E2 human papilloma virus 16 viral gene in cervical preneoplastic and neoplastic lesions. J Clin Virol 21: 129-134.
22. De Marco L, Gillio-Tos A, Bonello L, Ghisetti V, Ronco G, Merletti F (2007) Detection of human papillomavirus type 16 integration in preneoplastic cervical lesions and confirmation by DIPS-PCR and sequencing. J Clin Virol 38: 7-13.
23. Andersson S, Safari H, Mints M, Lewensohn-Fuchs I, Gyllensten U, Johansson B (2005) Type distribution, viral load and integration state of high-risk human papillomaviruses in pre-stages of cervical cancer (CIN). Br J Cancer 92: 2195-2200.
24. Hudelist G, Manavi M, Pischinger KID, Watkins-Riedel T, Singer CF, Kubista E, Czerwenka KF (2004) Physical state and expression of HPV DNA in benign and dysplastic cervical tissue: different levels of viral integration are correlated with lesion grade. Gynecol Oncol 92: 873-880.
25. Pett MR, Herdman MT, Palmer RD, Yeo GSH, Shivji MK, Stanley MA, Coleman N (2006) Selection of cervical keratinocytes containing integrated HPV16 associates with episome loss and an endogenous antiviral response. Proc Natl Acad Sci USA 103: 3822-3827.
26. Matovina M, Sabol I, Grubisić G, Gasperov NM, Grce M (2009) Identification of human papillomavirus type 16 integration sites in high-grade precancerous cervical lesions. Gynecol Oncol 113: 120-127.
27. Cheung JL, Lo KW, Cheung TH, Tang JW, Chan PK (2006) Viral load, E2 gene disruption status, and lineage of human papillomavirus type 16 infection in cervical neoplasia. J Infect Dis 194: 1706-1712.
28. Doeberitz V, Bauknecht M, Bartsch T, Zur Hauzen H (1991) Influence of chromosomal integration on glucocorticoid-regulated transcription of growth-stimulating papillomavirus genes E6 and E7 in cervical carcinoma cells. Proc Natl Acad Sci USA 18: 1411-1415.
29. Jeon S, Lambert PF (1995) Integration of human papillomavirus type 16 DNA into the human genome leads to increased stability of E6 and E7 mRNAs: implications for cervical carcinogenesis. Proc Natl Acad Sci USA 92: 1654-1658.
30. Jeon S, Allen-Hoffmann B, Lambert P (1995) Integration of human papillomavirus type 16 into the human genome correlates with a selective growth advantage of cells. J Virol 69: 2989-2997.
31. Boulet G, Horvath C, Vanden Broeck D, Sahebali S, Bogers J (2007) Human papillomavirus: E6 and E7 oncogenes. Int J Biochem Cell Biol 39: 2006-2011.
32. Storey A, Greenfield I, Banks L, Pim D, Crook T, Crawford L, Stanley M (1992) Lack of immortalizing activity of a human papillomavirus type 16 variant DNA with a mutation in the E2 gene isolated from normal human cervical keratinocytes. Oncogene 7: 459-465.
33. Casas I, Powell L, Klapper PE, Cleator GM (1995) New method for the extraction of viral RNA and DNA from cerebrospinal fluid for use in the polymerase chain reaction assay. J Virol Methods 53: 25-36.
34. Puranen M, Saarikoski S, Syrjänen K, Syrjänen S (1996) Polymerase chain reaction amplification of human papillomavirus DNA from archival, Papanicolaou-stained cervical smears. Acta Cytol 40: 391-395.
35. Sotlar K, Diemer D, Dethleffs A, Hack Y et al (2004) Detection and typing of human papillomavirus by e6 nested multiplex PCR. J Clin Microbiol 42: 3176-3184.
36. Collins SI, Constandinou-Williams C, Wen K, Young LS, Roberts S, Murray PG, Woodman CB (2009) Disruption of the E2 gene is a common and early event in the natural history of cervical human papillomavirus infection: a longitudinal cohort study. Cancer Res 69: 3828-3832.
37. Kulmala SM, Syrjδnen SM, Gyllensten UB et al (2006) Early integration of high copy HPV16 detectable in women with normal and low grade cervical cytology and histology. J Clin Pathol 59: 513-517.
38. Peitsaro P, Johansson B, Syrjanen S (2002) Integrated human papillomavirus type 16 is frequently found in cervical cancer precursors as demonstrated by a novel quantitative real-time PCR technique. J Clin Microbiol 40: 886-891.
39. Gallo G, Bibbo M, Bagella L et al (2003) Study of viral integration of HPV-16 in young patients with LSIL. J Clin Pathol 56: 532-536.
40. Azizi N, Brazete J, Hankins C, Money D et al (2008) Canadian Women's HIV Study Group. Influence of human papillomavirus type 16 (HPV-16) E2 polymorphism on quantification of HPV-16 episomal and integrated DNA in cervicovaginal lavages from women with cervical intraepithelial neoplasia. J Gen Virol 89: 1716-1728.
41. Giannoudis A, Duin M, Snijders PJ, Herrington CS (2001) Variation in the E2-binding domain of HPV 16 is associated with high-grade squamous intraepithelial lesions of the cervix. Br J Cancer 84: 1058-1063.
42. Jiang M, Baseman JG, Koutsky LA, Feng Q, Mao C, Kiviat NB, Xi LF (2009) Sequence variation of human papillomavirus type 16 and measurement of viral integration by quantitative PCR. J Clin Microbiol 47: 521-526.
43. Graham DA, Herrington CS (2000) HPV-16 E2 gene disruption and sequence variation in CIN 3 lesions and invasive squamous cell carcinomas of the cervix: relation to numerical chromosome abnormalities. Mol Pathol 53: 201-206.
44. Eriksson A, Herron JR, Yamada T et al (1999) Human papillomavirus type 16 variant lineages characterised by nucleotide sequence analysis of the E5 coding segment and the E2 hinge region. J Gen Virol 80: 595-600.
45. Casas L, Galvan SC, Ordoñez RM, Lopez N, Guido M, Berumen J (1999) Asian-american variants of human papillomavirus type 16 have extensive mutations in the E2 gene and are highly amplified in cervical carcinomas. Int J Cancer 83: 449-455.
46. Sathish N, Abraham P, Peedicayil A, Sridharan G, Shaji RV, Chandy G (2004) E2 sequence variations of HPV 16 among patients with cervical neoplasia seen in the Indian subcontinent. Gynecol Oncol 95: 363-369.
47. Watts KJ, Thompson CH, Cossart YE, Rose BR (2002) Sequence variation and physical state of human papillomavirus type 16 cervical cancer isolates from Australia and New Caledonia. Int J Cancer 97: 868-874.
48. Swan DC, Rajeevan M, Tortolero-Luna G, Follen M, Tucker RA, Unger ER (2005) Human papillomavirus type 16 E2 and E6/E7 variants. Gynecol Oncol 96: 695-700.
49. Meissner J (1997) Sequencing errors in reference HPV clones. In: Myers G, Munger K, Sverdrup F, McBride AA, Bernard HU, Meissner J (eds) Human Papillomavirus 1997: a compilation and analysis of nucleic acid and amino acid sequences. Los Alamos National Laboratory, NM, pp 110-123.
50. Veress G, Szarka K, Dong XP, Gergely L, Pfister H (1999) Functional significance of sequence variation in the E2 gene and the long control region of human papillomavirus type 16. J Gen Virol 80: 1035-1043.
51. Piccini A, Storey A, Massimi P, Banks L (1995) Mutations in the human papillomavirus type 16 E2 protein identify multiple regions of the protein involved in binding to E1. J Gen Virol 76: 2909-2913.